arrow
Y

Yun-Hyeong Cho

yonsei university health system
H指数:17
被引数:2,230

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents

药物洗脱支架患者的房颤治疗

2025-11-015
PRE
Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study

瑞舒伐他汀/氨氯地平固定剂量复方制剂在高血压和血脂异常患者中的疗效与安全性:一项多中心、前瞻性、观察性研究

2025-10-090
OAAI
Intravascular Imaging-Guided Optimization of Complex Percutaneous Coronary Intervention by Sex
2024-05-010
PRE
Impact of Intravascular Imaging-Guided Stent Optimization According to Clinical Presentation in Patients Undergoing Complex PCI
2024-05-012
PRE
Optical Coherence Tomography Compared With Intravascular Ultrasound and Angiography in Complex Coronary Artery Lesions
2024-03-010
PRE
Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention
2023-12-018
PRE
Prognostic Impact of Intravascular Imaging-Guided Percutaneous Coronary Intervention in Chronic Total Occlusion
2023-09-124
PRE
Intravascular Imaging-Guided or Angiography-Guided Complex PCI
2023-05-04166
PRE
Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial
2023-05-0118
PRE
Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial
2023-04-016
OAAI
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

中等强度他汀类药物联合依泽替米贝与高强度他汀类药物在糖尿病和动脉粥样硬化性心血管疾病患者中的RACING试验

2022-12-1929
OA
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
LANCET
IF88.5
2022-07-01158
PRE
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial
2022-01-0116
OAAI
Consensus Decision-Making for the Management of Antiplatelet Therapy before Non-Cardiac Surgery in Patients Who Underwent Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents: A Cohort Study
2021-04-208
OAAI
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction
2021-02-0119
OAAI